期刊文献+

肌醇脂质和cAMP在血小板活化因子诱导血小板聚集中的作用 被引量:1

Effect of inositol lipid and cAMP on PAF-induced platelet aggregation
下载PDF
导出
摘要 目的 :探讨肌醇脂质和cAMP两个细胞内第二信使系统在血小板活化因子 (PAF)诱导血小板聚集过程中所起到的作用和相互关系。方法 :采用PKC激动剂PMA和Ca2 + 通道A2 3 187,以及PKA激动剂Sp cAMPS和抑制剂Rp cAMPS干预的方法 ,分析观察这两个信使系统在PAF诱导血小板聚集过程中的作用 ;采用3 H Inositol和1 4 C Adenine双标记液体闪烁技术测定PAF诱导血小板可逆聚集过程中肌醇 1,4,5 三磷酸酯 (IP3 )和cAMP的水平变化的方法 ,分析研究这两个信使系统在PAF诱导血小板聚集过程中的相互关系。结果 :( 1)PMA和A2 3 187能分别增强PAF的血小板聚集效应 ,而且两者具有协同作用 ;( 2 )Rp cAMP和Sp cAMPS两者本身都不能引起血小板聚集 ,但能分别增强和抑制PAF的聚集效应 ;( 3 )IP3 和cAMP的水平变化分别与血小板的聚集和解聚过程一致。结论 :( 1)肌醇脂质信使系统是细胞内转导PAF诱导血小板聚集的主要胞内信使系统。 ( 2 )降低血小板内cAMP浓度不能诱导聚集 ,但能增强肌醇脂质信使系统的聚集效应 ;升高cAMP水平能拮抗肌醇脂质信使系统的作用 。 Objective:To investigate the effect of two intracellular second messenger systems,inositol lipid and cAMP,on PAF induced platelet aggregation.Methods:PAF induced platelet aggregation and levels of inositol 1,4,5 triphosphate(IP 3)and cAMP during the reversible phase of platelet aggregation were measured by platelet agglutometer and double labeled liquid scintillation technique with 3H inositol and 14 C adenine,respectively.Results:(1)phorbol myristate acetate(PKC agonist)and A23187 (calcium inophore)enhanced the PAF induced platelet aggregation response,and both had a synergistic effect.(2)Rp cAMPS(PKA antagonist)and Sp cAMPS(PKA agonist)promoted and inhibited the PAF induced platelet aggregation response,respectively,but both did not induce the platelet aggregation.(3)The increase and decrease of IP 3 and cAMP contents were related to the platelet aggregation and disaggregation.Conclusion:(1)Inositol lipid system plays a pivotal role in PAF induced platelet aggregation.(2)The decrease of cAMP level in platelets does not induce platelet aggregation,but reinforces the effect of inositol lipid system on platelet aggregation;the increase of cAMP concentration lessens the role of inositol lipid system in platelet aggregation,which could be an important mechanism in the disaggregation of reversible platelet aggregation.
出处 《广东医学院学报》 2004年第2期101-105,共5页 Journal of Guangdong Medical College
关键词 肌醇脂质 CAMP 细胞内信使系统 血小板活化因子 inositol lipid cAMP intracellular messenger system PAF
  • 相关文献

参考文献10

  • 1[1]Montrucchio G,Alloatti G,Camussi G.Role of platelet-activating factor in cardiovascular Pathophysiology[J].Physiol Rev,2000,80(4):1669-1699.
  • 2[2]Stafforini DM,McIntyre TM,Zimmerman GA,et al.Platelet-activating factor,a pleiotrophic mediator of physiological and pathological processes[J].Crit Rev Clin Lab Sci,2003,40(6):643-672.
  • 3[3]Montesi L,Muzzolini A,Borea PA,et al.Human platelet activation by PAF:receptor characterization[J].Pharmacol Res,1989,21(Suppl 1):119-120.
  • 4[4]Saunders RN,Handley DA.Platelet activating factor antagonists[J].Annu Rev Pharmacol Toxicol,1987,27:237-255.
  • 5[5]Handley DA.Preclinical and clinical pharmacology of platelet activating factor receptor antagonist[J].Med Res Rev,1990,10(3):351-370.
  • 6[6]Izquierdo I,Merlos M,Garcia-Rafanell J.Rupatadine:a new selective histamine H1 receptor and platelet-activating factor(PAF) antagonist.A review of pharmacological profile and clinical management of allergic rhinitis[J].Drugs today,2003,39(6):451-468.
  • 7[7]Chao W,Olson MS.Platelet-activating factor:receptors and signal transduction[J].Biochem J,1993,292(Pt3):617-629.
  • 8[8]Saeed SA,Rasheed H.Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation[J].Acta Pharmacol Sin,2003,24(1):31-36.
  • 9[9]Lauener RW,Stevens CM,Sayed MR,et al.A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low,but not high,concentrations of PAF or thrombin[J].Biochim Biophys Acta,1999,1452(2):197-208.
  • 10[10]Haslam RJ,Vanderwel M.Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine(platelet-activating factor)[J].J Biol Chem,1982,257(12):6879-6885.

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部